Psoriasis Treatment Center of New Jersey

Psoriasis Treatment Center of New Jersey is a specialty dermatology and psoriasis care center in East Windsor, New Jersey that operates as part of Schweiger Dermatology Group and was historically housed within Windsor Dermatology. The center focuses on diagnosis and treatment of psoriasis and related inflammatory skin diseases, while also serving as a clinical research site for dermatology studies. Publicly available information emphasizes its expertise in advanced psoriasis therapies and investigator-led or sponsor-supported clinical trials, including a 2023 open-label study of VTAMA added to injectable biologics in adult plaque psoriasis. It appears to function primarily as a specialty clinical practice and research center rather than as a drug-development biotech company with a proprietary pipeline.